Taylor Farms of Dallas, Texas, recalled the H-E-B Backyard BBQ Chop Salad Kit because the product may contain undeclared soy and almonds. …
Anthropic has acquired Mithril Medicine, a biotechnology company using artificial intelligence (AI) to develop experimental treatments for rare muscular dystrophy conditions. Completed …
The Therapeutic Goods Administration (TGA) has outlined new testing reforms for sun protection products after a major testing controversy. The new Australian …
Walmart is expanding its digital healthcare marketplace, Better Care Services, through a partnership with General Medicine, giving customers more ways to explore …
HealthSpan Partners, an affiliate of nonprofit health system Bon Secours Mercy Health, has agreed to acquire Surgery Partners in a transaction valued …
AstraZeneca’s experimental stomach cancer drug, sonesitatug vedotin (Sone-Ve), reduced the risk of death by 42% in a Phase 3 clinical trial involving …
Gilead Sciences has agreed to acquire PepStar Therapeutics’ oral inflammation drug program for $1.275 billion, strengthening its efforts to develop treatments for …
France has reported the first human case of Shamonda virus, a pathogen previously detected in animals, raising new questions about its ability …
Wedgewood Pharmacy has announced a nationwide recall of its products involving nearly 4,000 listings of compounded veterinary medications over concerns that some …
Swedish investment firm EQT has agreed to acquire molecular diagnostics company QIAGEN in an all-cash takeover deal valued at approximately €9.6 billion …
A team of researchers from the University of Sydney has identified a potential new depression subtype linked to disruptions in the body’s …
The US Food and Drug Administration (FDA) approved GSK’s hepatitis B drug Hibsago (bepirovirsen), introducing a new treatment option for certain adults …
Taylor Farms of Dallas, Texas, recalled the H-E-B Backyard BBQ Chop Salad Kit because the product may contain undeclared soy
Anthropic has acquired Mithril Medicine, a biotechnology company using artificial intelligence (AI) to develop experimental treatments for rare muscular dystrophy
The Therapeutic Goods Administration (TGA) has outlined new testing reforms for sun protection products after a major testing controversy. The
Walmart is expanding its digital healthcare marketplace, Better Care Services, through a partnership with General Medicine, giving customers more ways
HealthSpan Partners, an affiliate of nonprofit health system Bon Secours Mercy Health, has agreed to acquire Surgery Partners in a
AstraZeneca’s experimental stomach cancer drug, sonesitatug vedotin (Sone-Ve), reduced the risk of death by 42% in a Phase 3 clinical
Gilead Sciences has agreed to acquire PepStar Therapeutics’ oral inflammation drug program for $1.275 billion, strengthening its efforts to develop
France has reported the first human case of Shamonda virus, a pathogen previously detected in animals, raising new questions about
Wedgewood Pharmacy has announced a nationwide recall of its products involving nearly 4,000 listings of compounded veterinary medications over concerns
Swedish investment firm EQT has agreed to acquire molecular diagnostics company QIAGEN in an all-cash takeover deal valued at approximately
A team of researchers from the University of Sydney has identified a potential new depression subtype linked to disruptions in
The US Food and Drug Administration (FDA) approved GSK’s hepatitis B drug Hibsago (bepirovirsen), introducing a new treatment option for
